IBEX Technologies, Inc. (IBEX) is a biopharmaceutical company engaged in the production and sale of enzymes for use as reagents in hemostasis monitoring devices, and of arthritis diagnostic kits for pharmaceutical research. It is principally engaged in the production and sale of diagnostic products. IBEX sells its products, enzymes and diagnostic kits, either directly or through distributors. It has focused on the isolation, characterization and high-level expression of glycosaminoglycan GAG lyase enzymes derived from Flavobacterium heparinum, a non-pathogenic soil organism. IBEX has developed a Flavobacterium heparinum production system. This system allows the production of recombinant forms of these GAG lyases. IBEX produces heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B.
(Source: ARS)
